Literature DB >> 11673026

Epilepsy and trisomy 19q--different seizure patterns in a brother and a sister.

T Dorn1, M Riegel, A Schinzel, A M Siegel, G Krämer.   

Abstract

In symptomatic epilepsies due to chromosomal aberrations, epileptogenesis may be either the direct consequence of deletion or duplication of a gene causing seizures or may have a more complex etiology caused by the disturbance of the interaction of several genes and environmental factors. We report on a brother and a sister with trisomy 19q13.3-->qter who present different epileptologic features and discuss epileptogenesis in this syndrome with respect to genes known to be located on the distal part of chromosome 19q. Both patients share mental retardation and several dysmorphic features. The boy was hypoxic at birth and showed an extremely delayed psychomotor development. The girl, however, had no significant neonatal problems, and her psychomotor development was better. Although the male had an abnormal EEG in childhood, his first partial seizures occurred only as late as at age 31 years. He subsequently became seizure-free with carbamazepine (CBZ). In contrast, the girl already suffered from absence-like seizures during childhood and became seizure-free under ethosuccimide (ESM). A photoparoxysmal response, however, is still visible in her EEG. The difference between the epileptologic features in these siblings points to epileptogenic mechanisms placed far downstream on the way from genotype to phenotype. The photoparoxysmal response--otherwise a facultative finding in genetically determined epilepsies--in the EEG of the sister, however, points to a closer relationship between the duplicated genes and epileptogenesis. The fact that genes encoding potassium channels are located on 19q13.3-q13.4 may also support the latter assumption.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11673026     DOI: 10.1016/s0920-1211(01)00303-5

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  3 in total

1.  Identification of the variant Ala335Val of MED25 as responsible for CMT2B2: molecular data, functional studies of the SH3 recognition motif and correlation between wild-type MED25 and PMP22 RNA levels in CMT1A animal models.

Authors:  Alejandro Leal; Kathrin Huehne; Finn Bauer; Heinrich Sticht; Philipp Berger; Ueli Suter; Bernal Morera; Gerardo Del Valle; James R Lupski; Arif Ekici; Francesca Pasutto; Sabine Endele; Ramiro Barrantes; Corinna Berghoff; Martin Berghoff; Bernhard Neundörfer; Dieter Heuss; Thomas Dorn; Peter Young; Lisa Santolin; Thomas Uhlmann; Michael Meisterernst; Michael Werner Sereda; Michael Sereda; Ruth Martha Stassart; Gerd Meyer zu Horste; Klaus-Armin Nave; André Reis; Bernd Rautenstrauss
Journal:  Neurogenetics       Date:  2009-03-17       Impact factor: 2.660

2.  19q13.33→qter trisomy in a girl with intellectual impairment and seizures.

Authors:  Gianna Carvalheira; Mariana Moysés Oliveira; Sylvia Takeno; Fernanda Teresa de Lima; Vera Ayres Meloni; Maria Isabel Melaragno
Journal:  Meta Gene       Date:  2014-10-27

3.  Duplications at 19q13.33 in patients with neurodevelopmental disorders.

Authors:  Eduardo Pérez-Palma; Elmo Saarentaus; Marie Ravoet; Giancarlo V De Ferrari; Peter Nürnberg; Bertrand Isidor; Bernd A Neubauer; Dennis Lal
Journal:  Neurol Genet       Date:  2018-01-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.